Loading chart…
LIVE
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals.
Sun Pharmaceutical Industries Limited (SUNPHARMA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The SUNPHARMA share price is ₹1,804.10 (+1.37% today), with a market capitalisation of ₹4.33T and a price-to-earnings (P/E) ratio of 35.3. MarketRipple tracks the SUNPHARMA investment thesis, the ripple-chain impact of market events on Sun Pharmaceutical Industries Limited, and the Healthcare sector outlook.
Open
₹1,797.10
High
₹1,797.10
Low
₹1,797.10
Prev. Close
₹1,779.70
52W High
₹2,046.90
52W Low
₹1,583.70
Day range
₹1,797.10–₹1,797.10
52-week range
₹1,583.70–₹2,046.90
Volume
1.5M
P/E
35.3
ROE
13.7%
D/E
0.06
Margin
20.2%
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) is currently trading at ₹1,804.10 (+1.37%).
Sun Pharmaceutical Industries Limited's market capitalization is ₹4.33T.
Sun Pharmaceutical Industries Limited's price-to-earnings (P/E) ratio is 35.3.
Sun Pharmaceutical Industries Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Sun Pharmaceutical Industries Limited currently reads positive, based on 32 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.